Literature DB >> 8419928

Apolipoprotein B mRNA editing is associated with UV crosslinking of proteins to the editing site.

N Navaratnam1, R Shah, D Patel, V Fay, J Scott.   

Abstract

Apolipoprotein (apo) B100 mRNA undergoes editing of C-6666 to a U residue, which generates a stop-translation codon and defines the carboxyl terminus of apoB48. To aid purification of the editing enzyme we have undertaken UV crosslinking of a 32P-labeled substrate for apoB mRNA editing in vitro to proteins in an enterocyte editing extract. Proteins of 60 (p60) and 43 (p43) kDa, prominent among crosslinking bands, were competed for by unlabeled substrate, but not by nonspecific RNA, and did not crosslink to antisense RNA. Editing in vitro and UV crosslinking were inhibited by NaCl and vanadyl ribonucleoside complexes and by chemical modification of sulfhydryl, imidazolium, and guanidinium groups on the protein. The editing activity copurified predominantly with p60. To define the binding site for p60 on the substrate RNA, a series of scanning and point mutant RNAs, previously used to define nucleotides 6671-6681 as essential for editing, were used in competition studies with wild-type substrate. Results demonstrated that p60 binding is centered on nucleotides 6671-6674. We suggest that p60 contains the RNA-recognition component of the apoB mRNA-editing enzyme.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8419928      PMCID: PMC45632          DOI: 10.1073/pnas.90.1.222

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  22 in total

1.  Characterization of apolipoprotein B mRNA editing from rabbit intestine.

Authors:  Z C Garcia; K S Poksay; K Boström; D F Johnson; M E Balestra; I Shechter; T L Innerarity
Journal:  Arterioscler Thromb       Date:  1992-02

2.  Identification of a high-affinity RNA-binding site for the human immunodeficiency virus type 1 Rev protein.

Authors:  L S Tiley; M H Malim; H K Tewary; P G Stockley; B R Cullen
Journal:  Proc Natl Acad Sci U S A       Date:  1992-01-15       Impact factor: 11.205

3.  RNA binding site of R17 coat protein.

Authors:  P J Romaniuk; P Lowary; H N Wu; G Stormo; O C Uhlenbeck
Journal:  Biochemistry       Date:  1987-03-24       Impact factor: 3.162

4.  A novel form of tissue-specific RNA processing produces apolipoprotein-B48 in intestine.

Authors:  L M Powell; S C Wallis; R J Pease; Y H Edwards; T J Knott; J Scott
Journal:  Cell       Date:  1987-09-11       Impact factor: 41.582

5.  An in vitro system for the editing of apolipoprotein B mRNA.

Authors:  D M Driscoll; J K Wynne; S C Wallis; J Scott
Journal:  Cell       Date:  1989-08-11       Impact factor: 41.582

6.  Apolipoprotein B-48 is the product of a messenger RNA with an organ-specific in-frame stop codon.

Authors:  S H Chen; G Habib; C Y Yang; Z W Gu; B R Lee; S A Weng; S R Silberman; S J Cai; J P Deslypere; M Rosseneu
Journal:  Science       Date:  1987-10-16       Impact factor: 47.728

Review 7.  Apolipoprotein B mRNA editing: a new tier for the control of gene expression.

Authors:  P Hodges; J Scott
Journal:  Trends Biochem Sci       Date:  1992-02       Impact factor: 13.807

8.  Thyroid hormone modulates the introduction of a stop codon in rat liver apolipoprotein B messenger RNA.

Authors:  N O Davidson; L M Powell; S C Wallis; J Scott
Journal:  J Biol Chem       Date:  1988-09-25       Impact factor: 5.157

9.  RNA editing of apolipoprotein B mRNA. Sequence specificity determined by in vitro coupled transcription editing.

Authors:  S H Chen; X X Li; W S Liao; J H Wu; L Chan
Journal:  J Biol Chem       Date:  1990-04-25       Impact factor: 5.157

10.  Sequence requirements for apolipoprotein B RNA editing in transfected rat hepatoma cells.

Authors:  M S Davies; S C Wallis; D M Driscoll; J K Wynne; G W Williams; L M Powell; J Scott
Journal:  J Biol Chem       Date:  1989-08-15       Impact factor: 5.157

View more
  24 in total

1.  Apolipoprotein B RNA editing enzyme-deficient mice are viable despite alterations in lipoprotein metabolism.

Authors:  J R Morrison; C Pászty; M E Stevens; S D Hughes; T Forte; J Scott; E M Rubin
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-09       Impact factor: 11.205

2.  NMR structure of the apoB mRNA stem-loop and its interaction with the C to U editing APOBEC1 complementary factor.

Authors:  Christophe Maris; James Masse; Ann Chester; Naveenan Navaratnam; Frédéric H-T Allain
Journal:  RNA       Date:  2005-02       Impact factor: 4.942

Review 3.  RNA editing in plant mitochondria and chloroplasts.

Authors:  R M Maier; P Zeltz; H Kössel; G Bonnard; J M Gualberto; J M Grienenberger
Journal:  Plant Mol Biol       Date:  1996-10       Impact factor: 4.076

4.  Deficiency in APOBEC2 leads to a shift in muscle fiber type, diminished body mass, and myopathy.

Authors:  Yusuke Sato; Hans Christian Probst; Ryuichi Tatsumi; Yoshihide Ikeuchi; Michael S Neuberger; Cristina Rada
Journal:  J Biol Chem       Date:  2009-12-17       Impact factor: 5.157

5.  An AU-rich sequence element (UUUN[A/U]U) downstream of the edited C in apolipoprotein B mRNA is a high-affinity binding site for Apobec-1: binding of Apobec-1 to this motif in the 3' untranslated region of c-myc increases mRNA stability.

Authors:  S Anant; N O Davidson
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

6.  Phosphorylation is a regulatory mechanism in apolipoprotein B mRNA editing.

Authors:  Z Chen; T L Eggerman; A P Patterson
Journal:  Biochem J       Date:  2001-08-01       Impact factor: 3.857

7.  Nucleolin stabilizes Bcl-X L messenger RNA in response to UVA irradiation.

Authors:  Jack Zhang; George Tsaprailis; G Tim Bowden
Journal:  Cancer Res       Date:  2008-02-15       Impact factor: 12.701

8.  Molecular cloning of a human small intestinal apolipoprotein B mRNA editing protein.

Authors:  C Hadjiagapiou; F Giannoni; T Funahashi; S F Skarosi; N O Davidson
Journal:  Nucleic Acids Res       Date:  1994-05-25       Impact factor: 16.971

9.  Optimization of apolipoprotein B mRNA editing by APOBEC1 apoenzyme and the role of its auxiliary factor, ACF.

Authors:  Ann Chester; Violetta Weinreb; Charles W Carter; Naveenan Navaratnam
Journal:  RNA       Date:  2004-07-23       Impact factor: 4.942

10.  The apolipoprotein B mRNA editing complex performs a multifunctional cycle and suppresses nonsense-mediated decay.

Authors:  Ann Chester; Angelika Somasekaram; Maria Tzimina; Adam Jarmuz; Jane Gisbourne; Raymond O'Keefe; James Scott; Naveenan Navaratnam
Journal:  EMBO J       Date:  2003-08-01       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.